Investors are growing more convinced Covid-19 vaccines will work.
They aren’t as sure shares of vaccine companies can keep soaring.
Real Life. Real News. Real Voices
Help us tell more of the stories that matterBecome a founding member
The investors, along with analysts and others scrutinizing the results from early trials, say the most advanced vaccine candidates didn’t cause serious side effects and helped produce antibodies that may be sufficient…
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe